Recipharm AB: Interim Report January-June 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

April-June 2014

· Net sales amounted to SEK 611 million (530), an increase of 15.4% compared to same quarter last year (12.2% in fixed FX-rates) · EBITDA increased by 31,3% compared to same quarter last year and amounted to SEK 99 million (75) · Operating profit (EBIT) amounted to SEK 74 million (52), giving an operating margin of 12.1% (9.9) · Profit after tax amounted to SEK 48 million (36), giving a net margin of 7.9% (6.7) · Earnings per share amounted to SEK 1.33 (1.40), after dilution SEK 1.33 kr (1.35)

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC